Srpski arhiv za celokupno lekarstvo 2022 Volume 150, Issue 11-12, Pages: 667-674
https://doi.org/10.2298/SARH211221110N
Full text ( 295 KB)
Cited by
Use of thyroid hormones in hypothyroid and euthyroid patients: A THESIS questionnaire survey of Serbian physicians
Nedeljković-Beleslin Biljana (University of Belgrade, Faculty of Medicine, University Clinical Centre of Serbia, Clinic of Endocrinology, Diabetes, and Metabolic Disorders, Belgrade, Serbia), biljana_beleslin@yahoo.mail
Attanasio Roberto (Associazione Medici Endocrinologi, Scientific Committee, Milan, Italy)
Hegedüs Laszlo (Odense University Hospital, Department of Endocrinology and Metabolism, Odense, Denmark)
Nagy Endre V. (University of Debrecen, Faculty of Medicine, Department of Medicine, Division of Endocrinology, Debrecen, Hungary)
Negro Roberto (Vito Fazzi Hospital, Division of Endocrinology, Lecce, Italy)
Papini Enrico (Regina Apostolorum Hospital, Department of Endocrinology and Metabolism, Rome, Italy)
Perros Petros (Royal Victoria Infirmary, Department of Endocrinology, Newcastle upon Tyne, United Kingdom)
Ćirić Jasmina (University of Belgrade, Faculty of Medicine, University Clinical Centre of Serbia, Clinic of Endocrinology, Diabetes, and Metabolic Disorders, Belgrade, Serbia)
Žarković Miloš (University of Belgrade, Faculty of Medicine, University Clinical Centre of Serbia, Clinic of Endocrinology, Diabetes, and Metabolic Disorders, Belgrade, Serbia)
Introduction/Objective. Hypothyroidism is a common disease and treatment with levothyroxine (LT4) is effective. However, variations in management are frequent. The aim of this study was to identify practices and attitudes of Serbian physicians relating to the treatment of hypothyroidism. Methods. An anonymized questionnaire was distributed electronically to members of the Serbian Thyroid Society, Serbian Association of Endocrine Surgeons, and Section for Endocrinology of the Serbian Medical Society. Results. Out of 170 invitations, 99 responses were received. LT4 was the first choice for the treatment of hypothyroidism in 90% of patients. After starting LT4 replacement therapy most respondents would recheck thyroid-stimulating hormone (TSH) in 4–6 weeks (n = 51, 62%) and in eight weeks (n = 29, 35%). In total, 61% of respondents (n = 60) indicated that they would consider treating euthyroid patients with LT4, the commonest indication being female infertility with high levels of thyroid antibodies (54%, n = 50). More than half respondents (58%, n = 45) would recommend combined LT4 + LT3 therapy for patients on LT4 with normal serum TSH who still complain of symptoms of hypothyroidism. 53% (n = 41/77), reported that the frequency of patients with normal serum TSH who still complain of hypothyroid symptoms is less than 5%. Conclusion. LT4 was the first choice of therapy for the treatment of hypothyroid patients, whereas LT3 + LT4 combination treatment is considered in patients with persistent symptoms of hypothyroidism despite normalization of TSH. The most common indication for thyroid hormone treatment in euthyroid patients was female infertility with high levels of thyroid antibodies. Alternative LT4 formulations like liquid solution or soft-gel capsules –formulations presently not available in Serbia, were largely reserved for specific conditions (interfering drugs, malabsorption, inability to take LT4 in the fasting state, unexplained poor biochemical control of hypothyroidism).
Keywords: THESIS, survey, Serbia, thyroid hormones, hypothyroidism, Levothyroxine
Show references
Garmendia Madariaga A, Santos Palacios S, Guillen-Grima F, Galofre JC. The incidence and prevalence of thyroid dysfunction in Europe: a meta-analysis. J Clin Endocrinol Metab. 2014;99(3):923- 31. [DOI: 10.1210/jc.2013-2409] [PMID: 24423323]
Nagy EV, Perros P, Papini E, Katko M, Hegedus L. New Formulations of Levothyroxine in the Treatment of Hypothyroidism: Trick or Treat? Thyroid. 2021;31(2):193-201. [DOI: 10.1089/thy.2020.0515] [PMID: 33003978]
Wiersinga WM, Duntas L, Fadeyev V, Nygaard B, Vanderpump MP. 2012 ETA Guidelines: The Use of L-T4 + L-T3 in the Treatment of Hypothyroidism. Eur Thyroid J. 2012;1(2):55-71. [DOI: 10.1159/000339444] [PMID: 24782999]
Pearce SH, Brabant G, Duntas LH, Monzani F, Peeters RP, Razvi S, et al. 2013 ETA Guideline: Management of Subclinical Hypothyroidism. Eur Thyroid J. 2013;2(4):215-28. [DOI: 10.1159/000356507] [PMID: 24783053]
Trbojević B, Žarković M, Artiko V, Beleslin B, Ćirić J, Ćirić S, et al. Nacionalni vodič dobre kliničke prakse za poremećaj rada štitaste žlezde. Beograd: Ministarstvo zdravlja Republike Srbije; 2011.
Iodine Global Network (IGN) - Serbia [Internet]. [cited 2022 May 19]. Available from: https://www.ign.org/serbia.htm
Jovanović V, Ivanović I, Krstić M, Medarevć A, Tomasević S, editors. Health Statistical Yearbook of Republic of Serbia 2019. Belgrade: Institute of Public Health of Serbia “Dr Milan Jovanović Batut”; 2020.
Winther KH, Papini E, Attanasio R, Negro R, Hegedus L. A 2018 European Thyroid Association Survey on the Use of Selenium Supplementation in Hashimoto’s Thyroiditis. Eur Thyroid J. 2020;9(2):99-105. [DOI: 10.1159/000504781] [PMID: 32257959]
Riis KR, Frolich JS, Hegedus L, Negro R, Attanasio R, Nagy EV, et al. Use of thyroid hormones in hypothyroid and euthyroid patients: A 2020 THESIS questionnaire survey of members of the Danish Endocrine Society. J Endocrinol Invest. 2021;44(11):2435-44. [DOI: 10.1007/s40618-021-01555-y] [PMID: 33774809]
Plowden TC, Schisterman EF, Sjaarda LA, Zarek SM, Perkins NJ, Silver R, et al. Subclinical Hypothyroidism and Thyroid Autoimmunity Are Not Associated With Fecundity, Pregnancy Loss, or Live Birth. J Clin Endocrinol Metab. 2016;101(6):2358-65. [DOI: 10.1210/jc.2016-1049] [PMID: 27023447]
Dhillon-Smith RK, Middleton LJ, Sunner KK, Cheed V, Baker K, Farrell-Carver S, et al. Levothyroxine in Women with Thyroid Peroxidase Antibodies before Conception. N Engl J Med. 2019;380(14):1316-25. [DOI: 10.1056/NEJMoa1812537] [PMID: 30907987]
Negro R, Attanasio R, Nagy EV, Papini E, Perros P, Hegedus L. Use of Thyroid Hormones in Hypothyroid and Euthyroid Patients; the 2019 Italian Survey. Eur Thyroid J. 2020;9(1):25-31. [DOI: 10.1159/000502057] [PMID: 32071899]
Borissova AMI, Boyanov MA, Attanasio R, Hegedus L, Nagy E, Negro R, et al. Use of Thyroid Hormones in Hypothyroid and Euthyroid Patients: a THESIS Questionnaire Survey of Bulgarian Physicians. Journal Endocrinologia. 2020;25(4):299-309.
Niculescu DA, Attanasio R, Hegedus L, Nagy E, Negro R, Papini E, et al. Use of Thyroid Hormones in Hypothyroid and Euthyroid Patients: a THESIS Questionnaire Survey of Romanian Physicians. Acta Endocrinol (Buchar). 2020;16(4):462-9. [DOI: 10.4183/aeb.2020.462] [PMID: 34084238]
Brandt F, Thvilum M, Almind D, Christensen K, Green A, Hegedus L, et al. Hyperthyroidism and psychiatric morbidity: evidence from a Danish nationwide register study. Eur J Endocrinol. 2013;170(2):341-8. [DOI: 10.1530/EJE-13-0708] [PMID: 24282192]
Fallahi P, Ferrari SM, Ruffilli I, Ragusa F, Biricotti M, Materazzi G, et al. Advancements in the treatment of hypothyroidism with L-T4 liquid formulation or soft gel capsule: an update. Expert Opin Drug Deliv. 2017;14(5):647-55. [DOI: 10.1080/17425247.2016.1227782] [PMID: 27552635]
Batbaatar E, Dorjdagva J, Luvsannyam A, Savino MM, Amenta P. Determinants of patient satisfaction: a systematic review. Perspect Public Health. 2017;137(2):89-101. [DOI: 10.1177/1757913916634136] [PMID: 27004489]
Jackson JL, Chamberlin J, Kroenke K. Predictors of patient satisfaction. Soc Sci Med. 2001;52(4):609-20. [DOI: 10.1016/s0277-9536(00)00164-7] [PMID: 11206657]
Saravanan P, Chau WF, Roberts N, Vedhara K, Greenwood R, Dayan CM. Psychological well-being in patients on ‘adequate’ doses of l-thyroxine: results of a large, controlled community-based questionnaire study. Clin Endocrinol (Oxf). 2002;57(5):577-85. [DOI: 10.1046/j.1365-2265.2002.01654.x] [PMID: 12390330]
Wekking EM, Appelhof BC, Fliers E, Schene AH, Huyser J, Tijjsen J, et al. Cognitive functioning and well-being in euthyroid patients on thyroxine replacement therapy for primary hypothyroidism. Eur J Endocrinol. 2005;153(6):747-53. [DOI: 10.1530/eje.1.02025] [PMID: 16322379]
Panicker V, Evans J, Bjoro T, Asvold BO, Dayan CM, Bjerkeset A. A paradoxical difference in relationship between anxiety, depression and thyroid function in subjects on and not on T4: findings from the HUNT study. Clin Endocrinol. 2009;71(4):574-80. [DOI: 10.1111/j.1365-2265.2008.03521.x] [PMID: 19751298]
Mitchell A, Hegedus L, Žarković M, Hickey JL, Perros P. Patient satisfaction and quality of life in hypothyroidism: An online survey by the British Thyroid Foundation. Clin Endocrinol (Oxf). 2021;94(3):513-20. [DOI: 10.1111/cen.14340] [PMID: 32978985]